ERBB2 and breast carcinoma: The aims of the current study were to evaluate the concordance of HER2 results between HERmark and routine HER2 testing methods, and to correlate the results obtained by various HER2 methods with overall survival (OS) of breast cancer patients in a multicenter Collaborative Biomarker Study (CBS) involving 11 study sites.